Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred S Lewin

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
Annals of Neurology|October 29, 2002
Rescue of a mitochondrial deficiency causing Leber Hereditary Optic NeuropathyJohn Guy, Xiaoping Qi, Francesco Pallotti, et al.
Investigative Ophthalmology & Visual Science|November 20, 2018
Clinically Relevant Outcome Measures for the I307N Rhodopsin Mouse: A Model of Inducible Autosomal Dominant Retinitis PigmentosaMichael T Massengill, Brianna Young, Deep Patel, et al.
Advances in Experimental Medicine and Biology|October 3, 2015
Conditional Induction of Oxidative Stress in RPE: A Mouse Model of Progressive Retinal DegenerationManas R Biswal, Cristhian J Ildefonso, Haoyu Mao, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 15, 2018
Cell-specific gene therapy driven by an optimized hypoxia-regulated vector reduces choroidal neovascularizationManas R Biswal, Howard M Prentice, George W Smith, et al.
Antioxidants (Basel, Switzerland)|May 27, 2026
Non-Erythropoietic EPO (EPO-R76E) Protects RPE Cells from Ferroptosis by Modulating the Labile Iron Pool and NRF2-GPX4 AxisSundaramoorthy Gopi, George T Prodanoff, Christopher L Passaglia, et al.
Novartis Foundation Symposium|January 31, 2004
Range of retinal diseases potentially treatable by AAV-vectored gene therapyWilliam W Hauswirth, Quihong Li, Brian Raisler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 12, 2013
NADH-dehydrogenase type-2 suppresses irreversible visual loss and neurodegeneration in the EAE animal model of MSVenu Talla, Hong Yu, Tsung-Han Chou, et al.
Investigative Ophthalmology & Visual Science|July 3, 2014
Mitochondrial oxidative stress in the retinal pigment epithelium leads to localized retinal degenerationHaoyu Mao, Soo Jung Seo, Manas R Biswal, et al.
Investigative Ophthalmology & Visual Science|April 24, 2009
Efficiency and safety of AAV-mediated gene delivery of the human ND4 complex I subunit in the mouse visual systemJohn Guy, Xiaoping Qi, Rajeshwari D Koilkonda, et al.
Vision Research|February 11, 2023
Binocular benefit following monocular subretinal AAV injection in a mouse model of autosomal dominant retinitis pigmentosa (adRP)Chulbul M Ahmed, Michael T Massengill, Cristhian J Ildefonso, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Annals of Neurology|October 29, 2002
Rescue of a mitochondrial deficiency causing Leber Hereditary Optic NeuropathyJohn Guy, Xiaoping Qi, Francesco Pallotti, et al.
Investigative Ophthalmology & Visual Science|November 20, 2018
Clinically Relevant Outcome Measures for the I307N Rhodopsin Mouse: A Model of Inducible Autosomal Dominant Retinitis PigmentosaMichael T Massengill, Brianna Young, Deep Patel, et al.
Advances in Experimental Medicine and Biology|October 3, 2015
Conditional Induction of Oxidative Stress in RPE: A Mouse Model of Progressive Retinal DegenerationManas R Biswal, Cristhian J Ildefonso, Haoyu Mao, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 15, 2018
Cell-specific gene therapy driven by an optimized hypoxia-regulated vector reduces choroidal neovascularizationManas R Biswal, Howard M Prentice, George W Smith, et al.
Antioxidants (Basel, Switzerland)|May 27, 2026
Non-Erythropoietic EPO (EPO-R76E) Protects RPE Cells from Ferroptosis by Modulating the Labile Iron Pool and NRF2-GPX4 AxisSundaramoorthy Gopi, George T Prodanoff, Christopher L Passaglia, et al.
Novartis Foundation Symposium|January 31, 2004
Range of retinal diseases potentially treatable by AAV-vectored gene therapyWilliam W Hauswirth, Quihong Li, Brian Raisler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 12, 2013
NADH-dehydrogenase type-2 suppresses irreversible visual loss and neurodegeneration in the EAE animal model of MSVenu Talla, Hong Yu, Tsung-Han Chou, et al.
Investigative Ophthalmology & Visual Science|July 3, 2014
Mitochondrial oxidative stress in the retinal pigment epithelium leads to localized retinal degenerationHaoyu Mao, Soo Jung Seo, Manas R Biswal, et al.
Investigative Ophthalmology & Visual Science|April 24, 2009
Efficiency and safety of AAV-mediated gene delivery of the human ND4 complex I subunit in the mouse visual systemJohn Guy, Xiaoping Qi, Rajeshwari D Koilkonda, et al.
Vision Research|February 11, 2023
Binocular benefit following monocular subretinal AAV injection in a mouse model of autosomal dominant retinitis pigmentosa (adRP)Chulbul M Ahmed, Michael T Massengill, Cristhian J Ildefonso, et al.
Pageof 13